ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Modified CRISPR Gene Editing Proves Highly Accurate – Asian Scientist Magazine

Asian Scientist MagazineModified CRISPR Gene Editing Proves Highly AccurateAsian Scientist MagazineThe main protagonist of the current third-generation DNA scissors is CRISPR, a tool that is quicker and cheaper than its predecessors. By cutting out a s… Continue reading

2017-04-24 Michael Zand NEWS

Modified CRISPR Gene Editing Proves Highly Accurate – Asian Scientist Magazine

Asian Scientist MagazineModified CRISPR Gene Editing Proves Highly AccurateAsian Scientist MagazineThe main protagonist of the current third-generation DNA scissors is CRISPR, a tool that is quicker and cheaper than its predecessors. By cutting out a s… Continue reading

2017-04-24 Michael Zand NEWS

Allied Physical Medicine in Dallas Joins R3 Stem Cell, Now Offering Regenerative Stem Cell Procedures – Benzinga

Allied Physical Medicine in Dallas Joins R3 Stem Cell, Now Offering Regenerative Stem Cell ProceduresBenzingaAllied Physical Medicine in Allen, Texas has joined R3 Stem Cell and is now offering regenerative stem cell procedures. The therapies are succe… Continue reading

2017-04-24 Michael Zand NEWS

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 – PR Newswire (press release)

Continue reading

2017-04-24 Michael Zand NEWS

Drs. Oz and Roizen: Put diabetes in remission; beware of stem-cell treatments for AMD – News Sentinel

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
PR Newswire (press release)
“Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022” report gives comprehensive insight on clinical and non-clinical developments in the field …

and more »

Continue reading

2017-04-24 Michael Zand NEWS

Immunotherapy Pioneer James Allison Has Unfinished Business … – MIT Technology Review

Drs. Oz and Roizen: Put diabetes in remission; beware of stem–cell treatments for AMD
News Sentinel
Q: I hear there’s a clinic in Canada that can medically cure Type 2 diabetes without bariatric surgery. I was diagnosed two years ago. Is this true? — William T., Bozeman, Mont. A: It’s almost true. Because Type 2 is a chronic disease, when you have …

and more »

Continue reading

2017-04-24 Michael Zand NEWS

In Pittsburgh, oral immunotherapy treatment for allergies in its infancy – Pittsburgh Post-Gazette


MIT Technology Review

Immunotherapy Pioneer James Allison Has Unfinished Business …
MIT Technology Review
On the day I arrive at MD Anderson Cancer Center in Houston to meet James Allison and his longtime collaborator Padmanee Sharma, they are nowhere to be …
CRISPR genome editing and immunotherapy – the early adopterMedical Xpress
Cancer immunotherapy market forecast to 2021 available in new …WhaTech

all 5 news articles »

Continue reading

2017-04-24 Michael Zand NEWS

Streamlining Stem Cell Manufacturing – Genetic Engineering & Biotechnology News (press release)


Pittsburgh Post-Gazette

In Pittsburgh, oral immunotherapy treatment for allergies in its infancy
Pittsburgh Post-Gazette
Six-year-old Eva of Mt. Lebanon is one of just a few children in Pittsburgh receiving oral immunotherapy (OIT) for a peanut allergy. Dissolved inside Eva’s fruit punch Kool-Aid was a minuscule amount of peanut powder. Two months ago, it would have …

Continue reading

2017-04-24 Michael Zand NEWS
  • 1
  • …
  • 1,812
  • 1,813
  • 1,814
  • 1,815
  • 1,816
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Engineering & Biotechnology News (press release)

Streamlining Stem Cell Manufacturing
Genetic Engineering & Biotechnology News (press release)
Stem cell therapies hold extraordinary potential to revolutionize human medicine. Indeed, the global market for cell-based therapies is expected to surpass $20 billion by 2025, with an annual growth rate of 21%, as estimated by Scientia Advisors …